RESONANCE HEALTH LIMITED - Announcements

Market Cap $35.75M Add to my watchlist

Healthcare Medical Devices

Resonance Health Limited is an Australia-based MedTech company. The Company specializes... Resonance Health Limited is an Australia-based MedTech company. The Company specializes in the development and delivery of non-invasive medical imaging software and services. The Company is engaged in the development and commercialization of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its portfolio includes Core Lab and artificial intelligence (AI) powered products to partner with clinicians and radiologists for diagnosis, and management of patients in a variety of clinical settings. Its core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company's other SaMDs include Cardiac T2, for the assessment of iron in the heart, and HepaFat-Scan for the assessment of fat in and around the liver. The Company also has several AI-assisted SaMDs, including FerriSmart, HepaFat-AI, and LiverSmart.More

Announcements

Filter Results

All Price Sensitive Only

RHT	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/21	369.25KB	Share
RHT	Appointment of CFO & Company Secretary		08/04/21	212.17KB	Share
RHT	Change of Director's Interest Notice		09/03/21	581.11KB	Share
RHT	Secondary Trading Notice & Appendix 2A		09/03/21	386.13KB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	1.04MB	Share
RHT	HepaFat-AI receives CE Marking	PRICE SENSITIVE	24/02/21	252.4KB	Share
RHT	HepaFat-AI Receives TGA Approval	PRICE SENSITIVE	18/02/21	280.7KB	Share
RHT	Trading Halt	PRICE SENSITIVE	17/02/21	570.06KB	Share
RHT	Pause in Trading	PRICE SENSITIVE	17/02/21	116.7KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/21	397.37KB	Share
RHT	Secondary Trading Notice & Appendix 2A		12/01/21	626.95KB	Share
RHT	Secondary Trading Notice & Appendix 2A		31/12/20	387.43KB	Share
RHT	Secondary Trading Notice & Appendix 2A		29/12/20	3.11MB	Share
RHT	HepaFat-AI Incorporated into Blackford Analysis	PRICE SENSITIVE	24/12/20	153.07KB	Share
RHT	Secondary Trading Notice & Appendix 2A		11/12/20	385.6KB	Share
RHT	HepaFat-AI gains US FDA clearance	PRICE SENSITIVE	09/12/20	553.37KB	Share
RHT	Trading Halt	PRICE SENSITIVE	08/12/20	198.54KB	Share
RHT	Pause in Trading	PRICE SENSITIVE	08/12/20	116.61KB	Share
RHT	Secondary Trading Notice & Appendix 2A		27/11/20	385.79KB	Share
RHT	Results of Meeting		19/11/20	89.05KB	Share
RHT	Investor Presentation November 2020		19/11/20	1.63MB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	26/10/20	375.72KB	Share
RHT	Notice of Annual General Meeting/Proxy Form		16/10/20	162.23KB	Share
RHT	Secondary Trading Notice & Appendix 2A		09/10/20	627.25KB	Share
RHT	New Pulmonary Embolism AI Solution Developed	PRICE SENSITIVE	06/10/20	151.84KB	Share
RHT	Appendix 4G and Corporate Governance Statement		30/09/20	310.83KB	Share
RHT	Annual Report to shareholders		30/09/20	4.66MB	Share
RHT	Proposed issue of Securities - RHT		10/09/20	24.65KB	Share
RHT	Execution of Licence Agreement	PRICE SENSITIVE	10/09/20	441.01KB	Share
RHT	Preliminary Final Report	PRICE SENSITIVE	20/08/20	420.51KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/07/20	397.3KB	Share
RHT	Additional Information on Announcement Dated 25 May 2020		26/05/20	73.78KB	Share
RHT	Resonance Health Files New Provisional Patent	PRICE SENSITIVE	25/05/20	142.25KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/20	709.11KB	Share
RHT	510(k) Application Submission to U.S. FDA		06/04/20	266.35KB	Share
RHT	Market Update	PRICE SENSITIVE	31/03/20	132.87KB	Share
RHT	Secondary Trading Notice & Appendix 2A		20/03/20	204.07KB	Share
RHT	Proposed issue of Securities - RHT		19/03/20	25.14KB	Share
RHT	Controlled Placement Facility	PRICE SENSITIVE	19/03/20	71.97KB	Share
RHT	Secondary Trading Notice & Appendix 2A		06/03/20	203.27KB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	21/02/20	1.15MB	Share
RHT	Licencee & Royalty Agreement with 3DR Laboratories	PRICE SENSITIVE	04/02/20	342.92KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/20	615.03KB	Share
RHT	Appendix 3B and Secondary Trading Notice		13/01/20	931.77KB	Share
RHT	Change of Director's Interest Notice x 4		03/12/19	518.02KB	Share
RHT	Appendix 3B and Secondary Trading Notice		03/12/19	969.34KB	Share
RHT	Results of Meeting		28/11/19	2.06MB	Share
RHT	Resonance Health Partners with Siemens healthineers	PRICE SENSITIVE	28/11/19	107.3KB	Share
RHT	Investor Presentation November 2019		25/11/19	1.87MB	Share
RHT	New AI Tool for Automated Assessment of Liver Fat	PRICE SENSITIVE	21/11/19	238.73KB	Share
RHT	Resonance Health Files Provisional Patent	PRICE SENSITIVE	20/11/19	238.71KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/19	613.15KB	Share
RHT	Notice of Annual General Meeting/Proxy Form		25/10/19	225.43KB	Share
RHT	Updated Securities Trading Policy		22/10/19	95.81KB	Share
RHT	Annual Report to shareholders		22/10/19	5.74MB	Share
RHT	Appendix 4G and Corporate Governance Statement		22/10/19	157.54KB	Share
RHT	Full Year Statutory Accounts		27/09/19	1.33MB	Share
RHT	Preliminary Final Report	PRICE SENSITIVE	27/08/19	562.49KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/19	633.31KB	Share
RHT	Resonance Health contracted new clinical trials	PRICE SENSITIVE	19/07/19	256.83KB	Share
RHT	Appendix 3B and Secondary Trading Notice		16/07/19	406.95KB	Share
RHT	Secondary Trading Notice		01/05/19	245.24KB	Share
RHT	R&D Activities Update and Appendix 3B	PRICE SENSITIVE	30/04/19	974.05KB	Share
RHT	Customer Newsletter - April 2019		16/04/19	515.02KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	16/04/19	385.85KB	Share
RHT	Response to ASX Price and Volume Query	PRICE SENSITIVE	15/04/19	220.51KB	Share
RHT	Investor Presentation March 2019		25/03/19	1.23MB	Share
RHT	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/19	870.74KB	Share
RHT	Change of Director's Interest Notice		05/02/19	68.51KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	21/01/19	383.24KB	Share
RHT	Execution of Distribution Agreement with EnvoyAI	PRICE SENSITIVE	15/01/19	254.94KB	Share
RHT	Execution of License Agreement	PRICE SENSITIVE	03/01/19	84.57KB	Share
RHT	Response to ASX Price and Volume Query	PRICE SENSITIVE	11/12/18	202.78KB	Share
RHT	FDA Clearance Granted for FerriSmart	PRICE SENSITIVE	03/12/18	83.38KB	Share
RHT	R&D Tax Incentive	PRICE SENSITIVE	20/11/18	80.42KB	Share
RHT	Change of Director's Interest Notice		16/11/18	98.78KB	Share
RHT	Results of Meeting		08/11/18	86.14KB	Share
RHT	AGM Presentation		08/11/18	604.62KB	Share
RHT	New Work Order to provide services for Clinical Trial	PRICE SENSITIVE	31/10/18	267.55KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/18	609.7KB	Share
RHT	Response to ASX Price and Volume Query	PRICE SENSITIVE	23/10/18	638.39KB	Share
RHT	Pause in Trading	PRICE SENSITIVE	23/10/18	117.81KB	Share
RHT	Notice of Annual General Meeting/Proxy Form		08/10/18	417.79KB	Share
RHT	Annual Report to shareholders		08/10/18	1.61MB	Share
RHT	Amended Appendix 3B		14/09/18	358.57KB	Share
RHT	Appendix 4G and Corporate Governance Statement		13/09/18	157.37KB	Share
RHT	Full Year Statutory Accounts		13/09/18	686.04KB	Share
RHT	Appendix 3B		13/09/18	109.79KB	Share
RHT	Change of Substantial Shareholder Notification		06/09/18	49.8KB	Share
RHT	Change of Director's Interest Notice		06/09/18	68.66KB	Share
RHT	Preliminary Final Report	PRICE SENSITIVE	30/08/18	329.84KB	Share
RHT	Additional Information on Announcement Dated 23 August 2018	PRICE SENSITIVE	27/08/18	89.81KB	Share
RHT	Trading Halt	PRICE SENSITIVE	27/08/18	995.61KB	Share
RHT	Resonance Health contracted for two new clinical trials	PRICE SENSITIVE	23/08/18	72.74KB	Share
RHT	Appendix 4C - quarterly	PRICE SENSITIVE	23/07/18	140.21KB	Share
RHT	TGA, CE Mark clearance for A.I. Solution FerriSmart	PRICE SENSITIVE	11/07/18	685.68KB	Share
RHT	Alliance Partner Agreement with Blackford Analysis	PRICE SENSITIVE	05/07/18	250.49KB	Share
RHT	Customer Newsletter - June 2018		29/06/18	748.07KB	Share
RHT	Investor Presentation June 2018		12/06/18	1.17MB	Share
RHT	Change of Director's Interest Notice		31/05/18	68.66KB	Share

RHT Appendix 4C - quarterly
29/04/21	PRICE SENSITIVE	369.25KB	Share
RHT Appointment of CFO & Company Secretary
08/04/21		212.17KB	Share
RHT Change of Director's Interest Notice
09/03/21		581.11KB	Share
RHT Secondary Trading Notice & Appendix 2A
09/03/21		386.13KB	Share
RHT Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	1.04MB	Share
RHT HepaFat-AI receives CE Marking
24/02/21	PRICE SENSITIVE	252.4KB	Share
RHT HepaFat-AI Receives TGA Approval
18/02/21	PRICE SENSITIVE	280.7KB	Share
RHT Trading Halt
17/02/21	PRICE SENSITIVE	570.06KB	Share
RHT Pause in Trading
17/02/21	PRICE SENSITIVE	116.7KB	Share
RHT Appendix 4C - quarterly
28/01/21	PRICE SENSITIVE	397.37KB	Share
RHT Secondary Trading Notice & Appendix 2A
12/01/21		626.95KB	Share
RHT Secondary Trading Notice & Appendix 2A
31/12/20		387.43KB	Share
RHT Secondary Trading Notice & Appendix 2A
29/12/20		3.11MB	Share
RHT HepaFat-AI Incorporated into Blackford Analysis
24/12/20	PRICE SENSITIVE	153.07KB	Share
RHT Secondary Trading Notice & Appendix 2A
11/12/20		385.6KB	Share
RHT HepaFat-AI gains US FDA clearance
09/12/20	PRICE SENSITIVE	553.37KB	Share
RHT Trading Halt
08/12/20	PRICE SENSITIVE	198.54KB	Share
RHT Pause in Trading
08/12/20	PRICE SENSITIVE	116.61KB	Share
RHT Secondary Trading Notice & Appendix 2A
27/11/20		385.79KB	Share
RHT Results of Meeting
19/11/20		89.05KB	Share
RHT Investor Presentation November 2020
19/11/20		1.63MB	Share
RHT Appendix 4C - quarterly
26/10/20	PRICE SENSITIVE	375.72KB	Share
RHT Notice of Annual General Meeting/Proxy Form
16/10/20		162.23KB	Share
RHT Secondary Trading Notice & Appendix 2A
09/10/20		627.25KB	Share
RHT New Pulmonary Embolism AI Solution Developed
06/10/20	PRICE SENSITIVE	151.84KB	Share
RHT Appendix 4G and Corporate Governance Statement
30/09/20		310.83KB	Share
RHT Annual Report to shareholders
30/09/20		4.66MB	Share
RHT Proposed issue of Securities - RHT
10/09/20		24.65KB	Share
RHT Execution of Licence Agreement
10/09/20	PRICE SENSITIVE	441.01KB	Share
RHT Preliminary Final Report
20/08/20	PRICE SENSITIVE	420.51KB	Share
RHT Appendix 4C - quarterly
28/07/20	PRICE SENSITIVE	397.3KB	Share
RHT Additional Information on Announcement Dated 25 May 2020
26/05/20		73.78KB	Share
RHT Resonance Health Files New Provisional Patent
25/05/20	PRICE SENSITIVE	142.25KB	Share
RHT Appendix 4C - quarterly
28/04/20	PRICE SENSITIVE	709.11KB	Share
RHT 510(k) Application Submission to U.S. FDA
06/04/20		266.35KB	Share
RHT Market Update
31/03/20	PRICE SENSITIVE	132.87KB	Share
RHT Secondary Trading Notice & Appendix 2A
20/03/20		204.07KB	Share
RHT Proposed issue of Securities - RHT
19/03/20		25.14KB	Share
RHT Controlled Placement Facility
19/03/20	PRICE SENSITIVE	71.97KB	Share
RHT Secondary Trading Notice & Appendix 2A
06/03/20		203.27KB	Share
RHT Half Yearly Report and Accounts
21/02/20	PRICE SENSITIVE	1.15MB	Share
RHT Licencee & Royalty Agreement with 3DR Laboratories
04/02/20	PRICE SENSITIVE	342.92KB	Share
RHT Appendix 4C - quarterly
29/01/20	PRICE SENSITIVE	615.03KB	Share
RHT Appendix 3B and Secondary Trading Notice
13/01/20		931.77KB	Share
RHT Change of Director's Interest Notice x 4
03/12/19		518.02KB	Share
RHT Appendix 3B and Secondary Trading Notice
03/12/19		969.34KB	Share
RHT Results of Meeting
28/11/19		2.06MB	Share
RHT Resonance Health Partners with Siemens healthineers
28/11/19	PRICE SENSITIVE	107.3KB	Share
RHT Investor Presentation November 2019
25/11/19		1.87MB	Share
RHT New AI Tool for Automated Assessment of Liver Fat
21/11/19	PRICE SENSITIVE	238.73KB	Share
RHT Resonance Health Files Provisional Patent
20/11/19	PRICE SENSITIVE	238.71KB	Share
RHT Appendix 4C - quarterly
28/10/19	PRICE SENSITIVE	613.15KB	Share
RHT Notice of Annual General Meeting/Proxy Form
25/10/19		225.43KB	Share
RHT Updated Securities Trading Policy
22/10/19		95.81KB	Share
RHT Annual Report to shareholders
22/10/19		5.74MB	Share
RHT Appendix 4G and Corporate Governance Statement
22/10/19		157.54KB	Share
RHT Full Year Statutory Accounts
27/09/19		1.33MB	Share
RHT Preliminary Final Report
27/08/19	PRICE SENSITIVE	562.49KB	Share
RHT Appendix 4C - quarterly
29/07/19	PRICE SENSITIVE	633.31KB	Share
RHT Resonance Health contracted new clinical trials
19/07/19	PRICE SENSITIVE	256.83KB	Share
RHT Appendix 3B and Secondary Trading Notice
16/07/19		406.95KB	Share
RHT Secondary Trading Notice
01/05/19		245.24KB	Share
RHT R&D Activities Update and Appendix 3B
30/04/19	PRICE SENSITIVE	974.05KB	Share
RHT Customer Newsletter - April 2019
16/04/19		515.02KB	Share
RHT Appendix 4C - quarterly
16/04/19	PRICE SENSITIVE	385.85KB	Share
RHT Response to ASX Price and Volume Query
15/04/19	PRICE SENSITIVE	220.51KB	Share
RHT Investor Presentation March 2019
25/03/19		1.23MB	Share
RHT Half Yearly Report and Accounts
25/02/19	PRICE SENSITIVE	870.74KB	Share
RHT Change of Director's Interest Notice
05/02/19		68.51KB	Share
RHT Appendix 4C - quarterly
21/01/19	PRICE SENSITIVE	383.24KB	Share
RHT Execution of Distribution Agreement with EnvoyAI
15/01/19	PRICE SENSITIVE	254.94KB	Share
RHT Execution of License Agreement
03/01/19	PRICE SENSITIVE	84.57KB	Share
RHT Response to ASX Price and Volume Query
11/12/18	PRICE SENSITIVE	202.78KB	Share
RHT FDA Clearance Granted for FerriSmart
03/12/18	PRICE SENSITIVE	83.38KB	Share
RHT R&D Tax Incentive
20/11/18	PRICE SENSITIVE	80.42KB	Share
RHT Change of Director's Interest Notice
16/11/18		98.78KB	Share
RHT Results of Meeting
08/11/18		86.14KB	Share
RHT AGM Presentation
08/11/18		604.62KB	Share
RHT New Work Order to provide services for Clinical Trial
31/10/18	PRICE SENSITIVE	267.55KB	Share
RHT Appendix 4C - quarterly
29/10/18	PRICE SENSITIVE	609.7KB	Share
RHT Response to ASX Price and Volume Query
23/10/18	PRICE SENSITIVE	638.39KB	Share
RHT Pause in Trading
23/10/18	PRICE SENSITIVE	117.81KB	Share
RHT Notice of Annual General Meeting/Proxy Form
08/10/18		417.79KB	Share
RHT Annual Report to shareholders
08/10/18		1.61MB	Share
RHT Amended Appendix 3B
14/09/18		358.57KB	Share
RHT Appendix 4G and Corporate Governance Statement
13/09/18		157.37KB	Share
RHT Full Year Statutory Accounts
13/09/18		686.04KB	Share
RHT Appendix 3B
13/09/18		109.79KB	Share
RHT Change of Substantial Shareholder Notification
06/09/18		49.8KB	Share
RHT Change of Director's Interest Notice
06/09/18		68.66KB	Share
RHT Preliminary Final Report
30/08/18	PRICE SENSITIVE	329.84KB	Share
RHT Additional Information on Announcement Dated 23 August 2018
27/08/18	PRICE SENSITIVE	89.81KB	Share
RHT Trading Halt
27/08/18	PRICE SENSITIVE	995.61KB	Share
RHT Resonance Health contracted for two new clinical trials
23/08/18	PRICE SENSITIVE	72.74KB	Share
RHT Appendix 4C - quarterly
23/07/18	PRICE SENSITIVE	140.21KB	Share
RHT TGA, CE Mark clearance for A.I. Solution FerriSmart
11/07/18	PRICE SENSITIVE	685.68KB	Share
RHT Alliance Partner Agreement with Blackford Analysis
05/07/18	PRICE SENSITIVE	250.49KB	Share
RHT Customer Newsletter - June 2018
29/06/18		748.07KB	Share
RHT Investor Presentation June 2018
12/06/18		1.17MB	Share
RHT Change of Director's Interest Notice
31/05/18		68.66KB	Share

REFRESH

First 2 3 4

(20min delay)
Last 8.0¢		Change 0.000(0.00%)		Mkt cap ! $35.75M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	81906	7.9¢

Sellers (Offers)

Price($)	Vol.	No.
8.1¢	70000	1

View Market Depth

No.	Vol.	Price($)
1	81906	0.079
1	6840	0.077
1	26078	0.075
1	68000	0.072
1	68200	0.071

Price($)	Vol.	No.
0.081	70000	1
0.082	76975	2
0.083	80000	1
0.085	28708	2
0.086	34482	1

Last trade - 10.06am 08/05/2024 (20 minute delay)

RHT (ASX) Chart

Day chart unavailable

RESONANCE HEALTH LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories